RCM Platforms That Include Prior Auth in Full Revenue Cycle

Why the current payer landscape makes auth harder to manage manually

Prior authorization is not a paperwork step that happens before the real revenue cycle starts. It is the revenue cycle's most common point of failure. A platform that actually integrates it, rather than bolting a submission portal onto the side, gets claims paid on time. One that doesn't leaves claims stuck in appeal purgatory for weeks. Practices evaluating "full RCM" platforms need a way to tell whether a vendor merely submits an auth request or actually closes the loop when a payer pushes back, and most vendor websites will not tell you which one you're buying.

The scale of the problem isn't abstract. The AMA's most recent physician survey finds that physicians complete roughly 40 prior authorizations per week per doctor, burning about 13 hours of physician and staff time weekly. CAQH's 2024 Index puts a manual prior auth transaction at around $11, versus $5.79 when it runs electronically, and that gap compounds fast once a practice is processing hundreds of requests a month. Cost per transaction only tells half the story, though. A denied claim tied to a missed or expired authorization is lost revenue, and no amount of efficient submission fixes that after the fact.

Payer rules are tightening on a fixed government timeline, and that timeline should be driving vendor selection right now, not next year. CMS-0057-F took operational effect January 1, 2026: standard prior auth decisions must land within 7 calendar days, expedited ones within 72 hours, and payers now have to give specific denial reasons instead of vague boilerplate. The rule covers Medicare Advantage, state Medicaid fee-for-service, CHIP, Medicaid and CHIP managed care, and Qualified Health Plans on the FFEs. Payer API requirements follow a year later, on January 1, 2027.

March 31, 2026 mattered too, maybe more than people realized at the time. It was the first public reporting deadline requiring insurers to post approval rates, denial rates, appeal overturn rates, and processing times. A practice can now actually look up how one payer's prior auth behavior stacks up against another's, instead of guessing based on last quarter's denials.

Then comes the bigger structural shift. FHIR R4-based Prior Authorization APIs go live January 1, 2027. Payers have to let providers submit requests, check status, and get decisions electronically through the EHR itself. Portal-hopping, the daily grind of logging into six different payer sites to check on six different requests, has a regulatory expiration date now.

Layered on top of all this is the WISeR Model, a six-year CMMI pilot running January 1, 2026 through December 31, 2031 in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. It targets traditional Medicare fee-for-service and covers specific services, things like skin substitutes, nerve stimulation, steroid injections for pain, cervical fusion, knee arthroscopy for osteoarthritis, and and related procedures, among others. WISeR uses AI to screen requests but requires a licensed clinician to sign off before any denial actually stands. It's called voluntary, but practices in those six states that skip prior auth submission for a targeted service get hit with prepayment review instead, which functionally makes it mandatory.

None of this is happening in a vacuum of good faith. The AMA's Prior Authorization Physician Survey found 61% of physicians believe AI-based PA review systems at major insurers produce more denials than a human reviewer would. In June 2025, more than 60 major insurers pledged to speed things up, committing to processing 80% of electronic prior auth approvals in real time by January 1, 2027. The AMA's response was that little has actually changed for patients and clinicians on the ground, and that skepticism is the right default until the reporting data proves otherwise.

Payer behavior is getting more rule-bound (fixed timelines, specific denial reasons) at the same time it's getting less predictable (AI-driven denials, wide swings in approval rates between insurers). Setting those two trends side by side sharpens the operational picture: a platform that tracks payer-specific patterns over time is doing something a generic, one-size-fits-all workflow cannot.

What denial data reveals about how much prior auth status drives revenue outcomes

KFF's analysis of 2025 data from 14 insurers, covering 25 million Medicare Advantage enrollees, 36 million Medicaid MCO enrollees, and 10.8 million ACA Marketplace enrollees, found average standard prior authorization denial rates of 12% in Medicare Advantage, 14% in Medicaid MCOs, and 18% in the ACA marketplace.

Averages hide a lot, though. Within Medicare Advantage, denial rates ranged from 5% at Elevance to 17% at UnitedHealth. Medicaid MCO denials ranged from 2% to 23%. ACA marketplace denials swung between 3% and 25%. Payer identity, not payer type, drives most of that spread. A platform's payer-specific intelligence matters as much as its general feature list.

Appeals get filed rarely, and when they do get filed, they win. KFF reports overturn rates of around two-thirds in Medicare Advantage, roughly half in Medicaid managed care, and a meaningful share in the ACA marketplace overall. A two-thirds overturn rate in Medicare Advantage means most of the original denials weren't fully justified. That's recoverable revenue sitting on the table because most practices don't have a workflow built to appeal systematically, only sporadically, when someone happens to notice.

Platform design turns into a revenue question, not a convenience question, right at the moment tracking stops. A platform that submits the auth request but stops watching once it's filed, never flagging the denial, never triggering an appeal, never feeding the denial reason back into how future claims get scrubbed, leaves exactly the revenue on the table that those KFF overturn numbers say is recoverable. Medicare Advantage plans alone receive tens of millions of prior authorization requests a year. At that volume, tracking status by memory or spreadsheet becomes a math problem, because the sheer number of requests overwhelms manual tracking. And the math doesn't work.

What "prior auth included" means across different integration depths

"Prior auth included" "Prior auth included" appears on nearly every RCM vendor's website, and it can mean at least four genuinely different things depending on who's saying it. Most practices assume they're buying the third or fourth tier below. Most are buying the second.

At the shallow end sits portal access: a centralized dashboard where staff submit requests without switching between ten payer sites. It cuts down on portal-hopping, but it doesn't cut the work itself, because nothing decides an auth is even required, nothing helps assemble the documentation, and nothing tracks where a request stands once it's out the door.

One tier up is automated submission. The platform figures out whether authorization is required and files the request on its own. Staff still gathers the supporting documentation and still checks on status by hand, so the front end gets faster while the middle of the process stays exactly as manual as before.

Full lifecycle automation is the third tier, and it's where the work genuinely starts to disappear from a staffer's plate. The platform detects the requirement, builds the payer-specific documentation packet, submits it, tracks status, flags an authorization before it expires, and surfaces a resubmission the moment a payer pushes back. Staff steps in on the exceptions, not the routine cases, which is a real shift in where human attention gets spent, not a cosmetic one.

The top tier is continuous loop integration: authorization status feeds directly into eligibility verification, claim scrubbing, and denial management in real time. A pending or expired auth blocks the claim from going out the door before it becomes a denial. A denial automatically kicks off an appeal workflow. No piece of the cycle operates in isolation, so a gap that starts at the authorization stage never gets the chance to surface as a denial three weeks later.

Most platforms marketing "prior auth" are the second tier or right at the edge of the third, and the marketing copy almost never says which. Four things separate real integration from a bolted-on portal: how deeply the platform reads and writes to the EHR (native versus manual bridging); how many payers it actually covers, including the hard ones like IPAs, state Medicaid, and delegated vendors such as eviCore; what percentage of requests complete without a staffer touching them; and the vendor's progress building toward the 2027 FHIR API mandate now rather than waiting for the deadline to force the issue. A vendor not building toward FHIR readiness today is setting a client up for a forced migration in the middle of a contract, at the worst possible time to switch systems.

CAQH's 2025 Index found electronic transactions helped the healthcare industry avoid an estimated $258 billion in administrative costs, a 17% jump year over year. CAQH also puts roughly $21 billion in savings still on the table, sitting in transactions that remain manual or half-manual, with prior authorization named as one of the biggest contributors to that leftover number.

A comparison of the leading full-RCM platforms with prior auth integration

Judged against that four-tier framework, the platforms on the market split by scale, specialty, and how much of the loop they actually close. None of them are interchangeable, and picking based on brand recognition alone is how a practice ends up back at tier two despite paying for tier four.

One large-scale player processes over $200 billion in payments annually across more than 1 million providers and 5,000-plus health plan connections, reporting a 98.5% first-pass clean claim rate. Its prior auth workflow reviews orders straight from the EHR, decides whether authorization is needed, files the request, and monitors payer status using AI and robotic process automation that adjusts as payer policy changes. It suits organizations that already run an EHR and want a best-of-breed RCM layer on top, though setup and integration run more complex than average, which is the practical ceiling on how fast a client reaches full Level 4 operation.

R1 RCM's Phare platform splits into three modules: Phare Access for self-service patient intake (insurance verification and prior auth live here), Phare Claim for autonomous coding and claim optimization, and Phare Flow for autonomous follow-up and denial management. Putting prior auth inside intake, next to insurance verification, rather than treating it as a separate downstream task, is the structural choice that matters most here. R1 partners with 95 of the top 100 health systems in its market and processes more than 270 million payer transactions a year, earning Best in KLAS recognition for 2026 and seven straight years of KLAS recognition overall. It's built for hospitals and health systems outsourcing all or part of the revenue cycle. It's not sized for an independent practice, and a small group shopping here is shopping in the wrong aisle.

Rhyme, formerly PriorAuthNow, builds direct connections between providers and payers so authorizations skip the portal, the fax, and the phone call entirely, enabling touchless authorization wherever the payer relationship allows it. Its network spans more than 300 health plans and processes over four million authorizations a year. That direct payer connectivity, where it applies, represents a structural reduction in work, not just a speed boost. In mid-October 2025, Rhyme announced a collaboration with Microsoft to surface touchless prior auth responses at the point of care through Dragon Copilot. Touchless only works where the payer participates, though, so a practice with an unusual payer mix should expect uneven results, not uniform ones.

Infinx's Patient Access Plus platform was rated top for provider-side prior authorization automation and PAIR readiness in Black Book's 2026 rankings. It runs orders against a large rules library and machine learning models to catch which cases need authorization and what documentation they'll require, then automates the submission and portal logins, manages attachments through Jopari, and handles faxes and status tracking. Its payer connectivity, spanning national commercial plans, Medicare, and state Medicaid programs through API, RPA, and auto-fax, makes it a strong fit for practices dealing with a complex or regional payer mix.

SPRY takes a specialty-first approach, building end-to-end RCM directly into the EMR for outpatient PT, OT, SLP, and chiropractic practices, rather than bolting a separate RCM tool onto an existing EMR. Eligibility, claim scrubbing, denial management, ERA posting, and patient payment collection all run off the same clinical data source. Its prior auth automation reportedly handles up to 80% of supported requests, cutting request time from over 20 minutes down to about 90 seconds, though full automation is currently limited to trained payer workflows like Carelon/BCBS, UnitedHealthcare, and Humana, with others still in development. Its generative AI tool drafts appeal letters automatically and spots patterns across denials, reportedly cutting resolution time by 40%, down to 24 to 48 hours versus an industry standard of two to three weeks. Within its specialty and supported payer set, this is Level 4 integration. Outside that set, the automation thins out fast, which matters if a practice's payer mix doesn't match SPRY's trained list.

CureMD runs a full revenue cycle covering real-time and batch eligibility verification, prior auth workflows, automated claims processing, payment posting, and denial management, with denial resubmission reported within 48 hours and vendor-reported collections up to 96%. It received recognition in Black Book's 2026 rankings and fits small to mid-sized practices that want billing handled with AI-backed support behind it, though those figures come from the vendor itself, and pricing is available only by direct contact, which makes side-by-side comparison harder than it should be.

NextGen RCM handles end-to-end claims submission, payment posting, and A/R cleanup, with eligibility verification built into its practice management tools and prior authorization workflows shaped around the practice's own needs. Its dashboards track more than 100 KPIs across all payers, including denials, collection rates, and days in A/R, which gives practices a granular view of exactly where in the cycle revenue is slipping.

Altair Health belongs in this conversation as a full revenue cycle service built around the idea that authorization gaps shouldn't be separable from the rest of the claims process. Rather than treating prior auth as a task that closes out once submitted, Altair Health ties eligibility verification, authorization status, claim submission, and denial and appeal management into one continuous workflow, so an expired or pending authorization becomes visible before it turns into a denial, not after.

Across every one of these platforms, the question a practice actually has to answer is which of the four tiers it's buying, not which tier the sales deck implies. That answer separates a denial caught in real time from one discovered three weeks later in an aging report, and by then the recoverable revenue KFF's overturn data points to has already been lost.